Recently, Prof. Zhang Zhenzhong’s research group from School of Pharmacy, ZZU, has made progress in the field of ROS-based anti-cancer therapy. Their research paper was published in the international journal Nano Letters, entitled “Sequential Intercellular Delivery Nanosystem for Enhancing ROS Induced Antitumor Therapy”, with doctoral candidate Wang Binghua as the first author, Prof. Zhang Zhenzhong as the corresponding author, and ZZU as the only completion unit.（translator Song Gencheng）